Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study
Christoph Losem,1 Michael Koenigsmann,2 Christine Rudolph3 1Praxis für Hämatologie und Onkologie, Neuss, 2Onkologisches Ambulanzzentrum, Marienstr, Hannover, 3Hospira Germany, A Pfizer Company, München, Germany Background: Symptomatic anemia is a frequent and severe comp...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-02-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/biosimilar-retacritr-epoetin-zeta-in-the-treatment-of-chemotherapy-i-peer-reviewed-article-OTT |